AbbVie traded at $142.55 this Tuesday August 16th, increasing $0.26 or 0.18 percent since the previous trading session. Looking back, over the last four weeks, AbbVie gained 4.69 percent. Over the last 12 months, its price rose by 19.13 percent. Looking ahead, we forecast AbbVie to be priced at 138.61 by the end of this quarter and at 127.29 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
142.55
Daily Change
0.18%
Yearly
19.13%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Eisai 6,187.00 -18.00 -0.29% -33.06%
AbbVie 142.55 0.26 0.18% 19.13%
Abbott 112.03 0.13 0.12% -9.60%
ALKERMES 26.45 -0.15 -0.56% -9.08%
Amgen 253.15 2.07 0.82% 9.49%
AstraZeneca 10,900.00 -68.00 -0.62% 24.83%
Astrazeneca 66.74 -0.07 -0.10% 12.45%
Biogen 219.64 -2.74 -1.23% -37.21%
BioMarin Pharmaceutical 95.03 -1.91 -1.97% 24.45%
Bristol-Myers Squibb 74.13 -0.40 -0.54% 7.50%
ChemoCentryx 50.86 0.05 0.10% 271.78%
Coherus Biosciences 13.39 -0.48 -3.46% -8.73%
Endo International 0.37 -0.004 -1.18% -90.21%
Gilead Sciences 66.33 0.12 0.18% -9.17%
GlaxoSmithKline 1,398.10 -26.90 -1.89% -8.37%
Horizon Pharma 64.08 -0.82 -1.26% -39.24%
Intercept Pharmaceuticals 18.07 -0.12 -0.66% 31.71%
Infinity Pharmaceuticals 1.53 0.26 20.47% -50.65%
Jazz Pharmaceuticals 158.72 -1.54 -0.96% 15.13%
J&J 167.57 1.48 0.89% -6.63%
Eli Lilly 310.31 -3.63 -1.16% 13.79%
Medtronic 95.31 0.11 0.12% -27.11%
Merck & Co 90.59 -0.01 -0.01% 16.45%
Neurocrine Biosciences 106.11 -1.28 -1.19% 15.58%
Novartis 80.92 -0.06 -0.07% -6.72%
Pacira 57.95 0.22 0.38% 0.47%
Pfizer 49.86 0.11 0.22% -1.11%
Perrigo 41.84 -0.02 -0.05% 0.38%
Ultragenyx Pharmaceutical 49.31 -1.89 -3.69% -44.41%
Regeneron Pharmaceuticals 648.70 5.41 0.84% 2.07%
Roche Holding 315.00 -0.65 -0.21% -14.86%
Revance Therapeutics 22.32 0.20 0.90% -14.02%
Sanofi 82.68 -3.91 -4.52% -7.77%
Teva Pharmaceutical Industries 11.03 -0.17 -1.52% 16.35%
UCB 73.08 -0.12 -0.16% -26.21%
United Therapeutics 221.66 3.30 1.51% 8.80%
Vertex Pharmaceuticals 303.00 -2.53 -0.83% 55.57%
Zoetis 171.79 -2.66 -1.52% -16.85%

Indexes Price Day Year
US500 4274 8.06 0.19% -2.87%

AbbVie
AbbVie Inc. (AbbVie) is a research-based biopharmaceutical company. The Company is engaged in research and development, manufacturing, commercialization and sale of medicines and therapies. AbbVie offers its products in various therapeutic categories, including Immunology products, which include Humira, Skyrizi and Rinvoq; Oncology products consists of Imbruvica and Venclexta; Aesthetics products include Botox Cosmetic, Juvederm Collection and other aesthetics; Neuroscience products, such as Botox Therapeutic, Vraylar, Duopa and Duodopa, and Ubrelvy; Eye care products consists of Lumigan, Alphagan and Restasis ; Women's health products incudes Lo Loestrin, Orilissa and other women's health; and Other key products, which includes Mavyret, Creon, Lupron, Linzess and Synthroid. The Company's products are sold worldwide directly to wholesalers, distributors, government agencies, health care facilities and independent retailers from AbbVie-owned distribution centers and public warehouses.